Delivery Order SPE2DB20D2104-SPE2DB23FU54Z
- Not listed
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $6,462.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $43,509.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,288.49 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of September 25, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xifaxan 550 mg tablets. The $7,918.17 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- The federal contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $25,845.94 for the procurement of Xifaxan 550 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with a completion date of May 17, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Xifaxan 550 mg tablets to support military and veterans' healthcare programs. The $8,613.32 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,201.01 and an ultimate completion date of April 25, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA) with a total ceiling value of $10,697.65. The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract was awarded on October 26, 2021, with an ultimate completion date of October 27, 2021, and is a firm fixed-price delivery order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a...
- The federal contract award summarizes a delivery order (SPE2DX15D6028|SPE2DX24FWKPJ) valued at $10,634.93 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Xifaxan 550mg tablets, a pharmaceutical product, with a performance period ending on March 25, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $37,247.17, is for the delivery of Xifaxan 550 mg tablets. The contract has a period of performance through September 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU54ZDelivery Order
The federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The $9,778.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award demonstrates Amerisourcebergen Drug Corp's role as a critical supplier of essential medications and medical commodities to the U.S. government's defense and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 7/25/23 |